Your position:  Homepage


The Drug Information Portal of the Bund (Federal Government) and the Laender (States)

The portal PharmNet.Bund provides information of the competent authorities about drugs.

Please note that from 26.10.2023 it will no longer be possible to submit variations according to Regulation (EC) No 1234/2008 via the application "Electronic Variation Submission". The sending of notifications of changes according to § 29 AMG and other notifications remains unaffected and is still required via the PharmNet.Bund portal.

With the deactivation of the variation branch, the double submission of variation applications via PharmNet.Bund and CESP is no longer necessary. Due to a change in procedure, the additional submission of variations via the PharmNet.Bund portal is no longer required. Variations are to be submitted exclusively via the CESP portal as of 26.10.2023. Please note that variations that have already been created but not yet sent can no longer be submitted from this date.

For Public Access

The information system contains administrative data concerning the authorisation of drugs as well as Summary of Product Characteristics (SPCs) and Patient Information Leaflets (PILs). Furthermore you can find information about:

  • Drug Information System
  • Pharmaceutical Brokers and Wholesaler
  • Clinical Trials

For Companies

Pharmaceutical companies and wholesaler are able to record their data and submit it online to the federal authorities. This includes:

  • Variation Submisson and Approval Exempt
  • Sunset Clause
  • Batch Releases
  • Results of Clinical Trials
  • Veterinary Sales
  • Product information texts
  • Supply Shortages
  • Notification of the graduated plan officer

For National Authorities

National authorities are able to research and record national data online. These applications are restricted to staff members of the federal authorities and are only available in German.

Please note:

Use of the PharmNet name is made possible through the friendly approval of Cerner Deutschland GmbH that - as a provider for healthcare information technology solutions - offers software solutions for pharmaceutical management in hospital pharmacies under this trademark. BfArM and Cerner Deutschland GmbH are not involved in a business relationship. is a cooperative project of the German regulatory authorities – Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)), the Paul-Ehrlich-Institut (PEI) and the Federal Office of Consumer Protection and Food Safety (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL)) – together with the Robert Koch Institute (RKI)). The project will be implemented in close cooperation with the competent authorities of the Laender coordinated by the Central Authority of the Laender for Health Protection with regard to Medicinal Products and Medical Devices (Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten (ZLG)).

Last modified: 2/16/24

Your position:  Homepage

This website uses session cookies to ensure login to closed areas. In order to optimize the website, we use the analysis tool Matomo. Our Matomo installation works without tracking cookies. You will find more detailed information and the possibilities to object to the use of Matomo in our data privacy declaration.